UBS Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.06M | Sell |
|
|||||
|
2025
Q2 | $4.87M | Sell |
|
|||||
|
2025
Q1 | $7.19M | Sell |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $2.42M | Sell |
|
|||||
|
2024
Q2 | $7.04M | Buy |
|
|||||
|
2024
Q1 | $5.4M | Buy |
|
|||||
|
2023
Q4 | $252K | Buy |
|
|||||
|
2023
Q3 | $76.1K | Sell |
|
|||||
|
2023
Q2 | $443K | Sell |
|
|||||
|
2023
Q1 | $861K | Sell |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $753K | Buy |
|
|||||
|
2022
Q2 | $482K | Sell |
|
|||||
|
2022
Q1 | $736K | Sell |
|
|||||
|
2021
Q4 | $874K | Buy |
|
|||||
|
2021
Q3 | $1.12M | Sell |
|
|||||
|
2021
Q2 | $2.93M | Sell |
|
|||||
|
2021
Q1 | $7.32M | Buy |
|
|||||
|
2020
Q4 | $9.32M | Buy |
|
|||||
|
2020
Q3 | $3.1M | Buy |
|
|||||
|
2020
Q2 | $485K | Sell |
|
|||||
|
2020
Q1 | $4.28M | Sell |
|
|||||
|
2019
Q4 | $12M | Buy |
|
|||||
|
2019
Q3 | $5.96M | Buy |
|
|||||
|
2019
Q2 | $2.45M | Buy |
|
|||||
|
2019
Q1 | $34K | Sell |
|
|||||
|
2018
Q4 | $68K | Sell |
|
|||||
|
2018
Q3 | $1.1M | Sell |
|
|||||
|
2018
Q2 | $853K | Buy |
|
|||||
|
2018
Q1 | $214K | Buy |
|
|||||
|
2017
Q4 | $41K | Sell |
|
|||||
|
2017
Q3 | $161K | Sell |
|
|||||
|
2017
Q2 | $149K | Buy |
|
|||||
|
2017
Q1 | $32K | Sell |
|
|||||
|
2016
Q4 | $61K | Buy |
|
|||||
|
2016
Q3 | $56K | Sell |
|
|||||
|
2016
Q2 | $105K | Buy |
|
|||||
|
2016
Q1 | $22K | Sell |
|
|||||
|
2015
Q4 | $273K | Buy |
|